Sector dividends Guard Therapeutics International AB
Equities
GUARD
SE0021181559
Biotechnology & Medical Research
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
27.80 SEK | -2.11% | -3.47% | -22.35% |
08-29 | First Patient Dosed in Guard Therapeutics' Phase 2B Study POINTER | CI |
08-27 | Guard Therapeutics Plans New SEK80 Million Rights Issue to Fund Kidney Drug Study | MT |
Yield (Y) | Yield (Y+1) | P/E ratio | Price to Book | EV / Sales | EV / EBITDA | EV / EBIT | Capi. ($) | ||
---|---|---|---|---|---|---|---|---|---|
+0.85% | +0.98% | 47.36x | 4.065 | 6.29x | 22.13x | 34.03x | 46.26B | ||
-.--% | -.--% | 31.26x | 6.276 | 3.6x | 14.96x | 17.68x | 43.91B | ||
-.--% | -.--% | -104.49x | 121.73 | 14.03x | -239.94x | -176.4x | 32.5B | ||
+0.26% | +0.26% | 74.54x | 2.356 | 11.37x | 39.29x | 62.41x | 29.51B | ||
-.--% | -.--% | -8.34x | 2.802 | 6.95x | -6.55x | -5.8x | 29.45B | ||
-.--% | -.--% | 32.3x | 2.461 | 3.18x | 14.72x | 15.84x | 24.74B | ||
-.--% | -.--% | 14.09x | 2.086 | 4.66x | 9.08x | 9.39x | 15.51B | ||
+0.44% | +0.46% | 60x | 4.901 | 9.31x | 26.57x | 29.45x | 11.43B | ||
-.--% | -.--% | 29.29x | 11.03 | 4.57x | 21.94x | 23.57x | 10.5B | ||
-.--% | -.--% | 50.75x | 2.750 | 5.32x | 14.33x | 18.65x | 10.2B | ||
-.--% | -.--% | 29.9x | 2.450 | 2.94x | 11.79x | 14.82x | 9.71B | ||
-.--% | -.--% | -13.12x | 10,934.39 | 10.35x | -12.68x | -12.07x | 7.07B | ||
-.--% | -.--% | -12.14x | 4.559 | 3532.93x | -8.95x | -8.83x | 7.04B | ||
+1.13% | +1.25% | 49.57x | 4.179 | 9.12x | 31.79x | 45.28x | 6.78B | ||
+0.79% | +1.08% | 24.85x | 1.906 | 4.39x | 14.73x | 19.44x | 5.54B | ||
-.--% | +0.58% | -69.47x | 73.97 | 9.49x | -20.74x | -20.71x | 5.48B | ||
-.--% | -.--% | -12.8x | 10.59 | - | -10.46x | -10.66x | 4.6B | ||
Average | +0.20% | +0.27% | 13.15x | 658.38 | 227.41x | -4.59x | 3.30x | 17.66B | |
Weighted average by Cap. | +0.21% | +0.25% | 15.98x | 275.39 | 91.00x | -12.89x | -0.50x |
MarketScreener is also available in this country: United States.
Switch edition